1 October 2024
Oryzon Webcast to Discuss FDA Feedback on End-of-Phase II Meeting and Plans for PORTICO-2 Phase III Trial with vafidemstat in Borderline Personality Disorder
Conference Call and Webcast: October 1st 2024 at 9:00 am EDT (15:00 pm CET)